AI & Digital Health

AI-powered personalized wellness ecosystem integrating blood pressure, glucose trends, meditation, weight optimization, and behavioral coaching — without entering regulated clinical territory

August 10, 2025

By Dr. Ebot Eyong

At E&E Medicals, we are excited to introduce eeMeds™, an AI-powered preventative wellness platform designed to unify fragmented lifestyle apps into a single adaptive personalization engine focused on sleep, stress, weight trends, movement, and behavioral optimization.

Read The Article

Partner With Dr. Eyong

At E&E Medicals, we are excited to introduce eeMeds™, our AI-powered preventative wellness platform. This innovative solution aims to unify fragmented lifestyle apps into a single, adaptive personalization engine, which we call "The AI-powered Lifestyle Intelligence Platform, or Your Personal Wellness Data Brain."

eeMeds goes beyond static content by dynamically optimizing user behavior across key areas, including sleep, stress, weight trends, and movement. Our focus is solely on wellness, allowing for rapid development and scalability.

We are currently raising a seed round to fund the following initiatives:

MVP and AI prototype development
Core engineering and product hires
Early beta launch and validation
Initial user-acquisition testing
Strategic wearable and ecosystem integrations

Our target for this seed raise is [$2.5M – $4.0M], which will support 12–18 months of product development and market validation. Our goal is to demonstrate strong early engagement, refine our personalization engine, and position eeMeds for scalable growth in future financing.

I would appreciate the opportunity for a brief conversation this week to share our vision and roadmap.

Best,

Dr. Ebot Eyong
Founder, E & E Medicals

For more information, visit https://eemedicals.com/

Explore More Publications

Continue exploring Dr. Ebot Eyong’s professional insights on healthcare regulation, FDA submissions, AI-enabled medical devices, quality systems, and global compliance strategy.

Cybersecurity & Cloud Systems

Cloud-Based Systems for Medical Devices: FDA Perspective

April 22, 2024

By Dr. Ebot Eyong

The FDA advocates adopting cloud-based systems for medical devices, highlighting benefits such as scalability, enhanced security, collaboration, innovation potential, and operational cost savings. This article explains FDA perspectives and best practices for cloud-based medical device systems.

Read Article

Cybersecurity & Cloud Systems

Cybersecurity Documentation for Premarket Approval (PMA) Submissions

February 9, 2024

By Dr. Ebot Eyong

Cybersecurity documentation is vital for PMA submissions to the FDA, ensuring device safety and effectiveness. This article outlines cybersecurity risk assessment, security controls, SBOM, vulnerability disclosure, incident response planning, labeling, monitoring, and documentation requirements.

Read Article

Real-World Evidence

Real-World Evidence (RWE) and Biocompatibility: Implications of ISO 10993-1:2025 for Medical Device Manufacturers

December 11, 2025

By Dr. Ebot Eyong

The revised ISO 10993-1 marks a significant shift in biocompatibility assessment by enabling risk-based justifications supported by real-world evidence. This article explores pre-market submissions, manufacturer implications, AI-enabled device challenges, and regulatory pitfalls.

Read Article

Real-World Evidence

FDA Update on Real-World Evidence: Implications for AI-Enabled Medical Devices

May 2, 2025

By Dr. Ebot Eyong

The U.S. Food and Drug Administration has updated its Real-World Evidence policies to allow greater use of large, well-curated data sources in medical device marketing submissions. This article explains how RWE may support safety and effectiveness for AI-enabled medical devices.

Read Article

View All Publications